Physician profile
Daniel Edward Gerow
NPI 1659834349
$16,303.60
in general payments reported to CMS, 2019-2025
9 companies · $7,497 in 2025
The $7,497 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $618 · 2021: $2,470 · 2022: $1,579 · 2023: $160 · 2024: $3,979 · 2025: $7,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $3,116 · Travel and Lodging: $3,094 · Education: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $3,115.95 |
| Travel and Lodging | $3,094.41 |
| Education | $425.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,078.29 | 2024-2025 | Trigen Intertan, Redapt, Evos |
| Medwest Associates | $4,267.15 | 2020-2023 | |
| Stryker Corporation | $2,778.17 | 2022-2025 | Mako, Variax, Triathlon |
| Medical Device Business Services, INC. | $1,911.05 | 2024-2025 | Actis, Velys, Attune |
| Zimmer Biomet Holdings, INC. | $1,075.77 | 2024-2025 | Oxford, G7, Persona |
| Total Joint Orthopedics, INC. | $635.96 | 2025 | |
| Depuy Synthes Sales INC. | $219.41 | 2024 | |
| Si-Bone, INC. | $179.07 | 2021-2022 | |
| Orthalign INC | $158.73 | 2024 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gerow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.